Suppliers / Crystal Pharmaceutical Suzhou

Crystal Pharmaceutical Suzhou

China 9 employees Updated 9 July 2026

Crystal Pharmaceutical Suzhou is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Upadacitinib US FDA 1
Valbenazine US FDA 1

Also appears on these molecule pages

Upadacitinib API

Questions about Crystal Pharmaceutical Suzhou

Does Crystal Pharmaceutical Suzhou hold a US DMF or a CEP?
Crystal Pharmaceutical Suzhou holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Crystal Pharmaceutical Suzhou make?
2 molecules are on record against Crystal Pharmaceutical Suzhou, including Upadacitinib and Valbenazine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Crystal Pharmaceutical Suzhou comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 1 molecule Apitoria Pharma shares 1 molecule Changzhou Pharmaceutical Factory shares 1 molecule Curia shares 1 molecule Lee Pharma shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability